Hostname: page-component-7b7567c8c-2n9c9 Total loading time: 0 Render date: 2026-11-15T21:28:00.263Z Has data issue: false hasContentIssue false
  • English
  • Français

Apolipoprotein E-ε4 frequency in deficit schizophrenia

Published online by Cambridge University Press:  16 April 2020

F Thibaut,
A Van der Elst,
D Campion,
C Martin,
B Coron,
S Dollfus,
TH Frebourg and
M Petit
F Thibaut
Affiliation:
Molecular Genetic Unit (Unité INSERM EPI 9906), IFR 23, CHU de Rouen
A Van der Elst
Affiliation:
Molecular Genetic Unit (Unité INSERM EPI 9906), IFR 23, CHU de Rouen
D Campion
Affiliation:
Molecular Genetic Unit (Unité INSERM EPI 9906), IFR 23, CHU de Rouen
C Martin
Affiliation:
Molecular Genetic Unit (Unité INSERM EPI 9906), IFR 23, CHU de Rouen
B Coron
Affiliation:
Research Group, Psychopathology and Schizophrenias (JE 2014), University of Medicine at Rouen and Caen, Rouen, France
S Dollfus
Affiliation:
Research Group, Psychopathology and Schizophrenias (JE 2014), University of Medicine at Rouen and Caen, Rouen, France
TH Frebourg
Affiliation:
Molecular Genetic Unit (Unité INSERM EPI 9906), IFR 23, CHU de Rouen
M Petit
Affiliation:
Molecular Genetic Unit (Unité INSERM EPI 9906), IFR 23, CHU de Rouen
Get access

Summary

The apolipoprotein E (ApoE) genotype has been found to affect the expression of several neuropsychiatric disorders. We determined ApoE genotype frequencies and their relationship to primary negative symptoms in 61 non-deficit and 45 deficit schizophrenic patients, and compared them with 98 control subjects. No difference was observed when genotype or allele frequencies were compared between the three groups. Our data do not support a role for ApoE in the phenotypic expression of schizophrenia.

Keywords

apolipoprotein Edeficit syndromeschizophrenia

Information

Type
Original Articles
Information
European Psychiatry , Volume 14 , Issue 3 , June 1999, pp. 148 - 151
Copyright
Copyright © European Psychiatric Association 1999

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Amador, XF, Kirkpatrick, B, Carpenter, WT, Yale, SA, Marcinko, LThe long term stability of the deficit syndrome. Schizophr Res 1996 ; 18 : 116–116.CrossRefGoogle Scholar
American Psychiatry Association, Diagnostic and Statistical Manual of Mental Disorders, 3rd edition 1987 Washington, DC: American Psychiatric PressGoogle Scholar
Andreasen, NC, Olsen, SA, Dennert, JWVentricular enlargement in schizophrenia: relationship to positive and negative symptoms. Am J Psychiatry 1982 ; 139 : 297–302.Google ScholarPubMed
Arendt, T, Schindler, C, Brükner, MK, Eschrich, K, Bigl, V, Zedlick, DPlastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein ε4allele. J Neurosci 1997 ; 17 : 516–529.CrossRefGoogle Scholar
Bickeböller, H, Campion, D, Brice, A, Amouyel, P, Hannequin, D, Didierjean, OApolipoprotein E and Alzheimer disease: genotype specific risks by age and sex. Am J Hum Genet 1996 ; 60 : 439–446.Google Scholar
Carpenter, WT, Buchanan, RW, Kirkpatrick, B, Tamminga, C, Wood, FStrong inference, theory testing, and the neuroanatomy of schizophrenia. Arch Gen Psychiatry 1993 ; 50 : 825–831.CrossRefGoogle ScholarPubMed
Corder, EH, Saunders, AM, Strittmatter, WJ, Schmechel, DE, Gaskell, PC, Small, GWGene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993 ; 261 : 921–923.CrossRefGoogle ScholarPubMed
Hixson, JE, Vernier, DTRestriction isotyping of human ApoE by gene amplification and cleavage with HhaI. Lipid Res 1990 ; 31 : 545–548.Google ScholarPubMed
Jönsson, E, Lannfelt, L, Engvall, B, Sedvall, GLack of association between schizophrenia and the apolipoprotein E epsilon 4 allele. Eur Arch Psychiatry Clin Neurosci 1996 ; 246 : 182–184.CrossRefGoogle ScholarPubMed
Joober, R, Rouleau, G, Fon, E, Lal, S, Palmour, R, Bloom, DApolipoprotein E genotype in schizophrenia. Am J Med Genet 1996 ; 67 : 235–235.CrossRefGoogle Scholar
Kay, SR, Fiszbein, A, Opler, LAThe positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987 ; 13 : 261–276.CrossRefGoogle Scholar
Kirkpatrick, B, Buchanan, RW, McKenney, PD, Alphs, LD, Carpenter, WTThe schedule for the deficit syndrome: an instrument for research in schizophrenia. Psychiatry Res 1989 ; 30 : 119–123.CrossRefGoogle Scholar
Lan, TH, Hong, CJ, Chen, JY, Sim, CBApolipoprotein E-epsilon 4 frequency in patients with schizophrenia. Biol Psychiatry 1997 ; 42 : 225–227.Google ScholarPubMed
Marneros, A, Deister, A, Rhode, AValidity of the negative/positive dichotomy for schizophrenic disorders under long-term conditions. Schizophr Res 1992 ; 7 : 117–123.CrossRefGoogle ScholarPubMed
Nathan, BP, Bellosta, S, Sanan, A, Weisgraber, KH, Mahley, RW, Pitas, REDifferential effects of apolipoproteins ε3and ε4on neuronal growth in vitro. Science 1997 ; 264 : 850–852.CrossRefGoogle Scholar
Overall, JE, Gorham, DEThe brief psychiatric rating scale. Psychol Rep 1961 ; 10 : 799–812.CrossRefGoogle Scholar
Pearlson, GD, Garbacz, DJ, Breakey, WR, Ahn, HS, Depaulo, JRLateral ventricular enlargement associated with persistent unemployment and negative symptoms in both schizophrenia and bipolar disorder. Psychiatry Res 1984 ; 12 : 1–9.CrossRefGoogle ScholarPubMed
Pickar, D, Malhotra, AK, Rooney, W, Breier, A, Goldman, DApolipoprotein E epsilon 4 and clinical phenotype in schizophrenia. Lancet 1997 ; 350 : 930–931.CrossRefGoogle Scholar
Powchik, P, Friedman, J, Haroutunian, V, Greenberg, D, Altsteil, L, Purohit, DApolipoprotein ε4in schizophrenia: a study of one hundred sixteen cases with concomitant neuropathological examination. Biol Psychiatry 1997 ; 42 : 296–298.CrossRefGoogle ScholarPubMed
Ribeyre, JM, Dollfus, S, Lesieur, P, Ménard, JF, Petit, MInstrument d'évaluation du syndrome déficitaire de la schizophrénie. Encephale 1994 ; 20 : 413–419.Google Scholar
Soininen, HS, Riekkinen, PJApolipoprotein E, memory and Alzheimer's disease. Trends Neurosci 1996 ; 19 : 224–228.CrossRefGoogle ScholarPubMed
Strittmatter, WJ, Saunders, AM, Schmechel, D, Pericak-Vance, M, Enghild, J, Salvesen, GSApolipoprotein E: high avidity binding to B amyloid and increased frequency of type 4 allele in late onset familial Alzheimer's disease. Proc Natl Acad Sci USA 1993 ; 90 : 1977–1981.CrossRefGoogle Scholar
Thibaut, F, Ribeyre, JM, Dourmap, N, Ménard, JF, Dollfus, S, Petit, MPlasma 3-methoxy-4-hydroxyphenylglycol and homovanillic acid measurements in deficit and non-deficit forms of schizophrenia. Biol Psychiatry 1998 ; 43 : 24–30.CrossRefGoogle Scholar
Zhu, S, Nothen, MM, Uhlhaas, S, Rietschel, M, Koerner, J, Lanczik, MApolipoprotein E genotype distribution in schizophrenia. Psychiatr Genet 1996 ; 6 : 75–79.CrossRefGoogle Scholar
Submit a response

Comments

No Comments have been published for this article.